Direct-to-consumer (DTC) telehealth companies remove barriers to care, but questions remain regarding patient safety and proper information.

New research from the UW School of Medicine shows telehealth services for medication abortion increased after the Dobbs ...

As justification for a review of a drug used in medication abortion, two health officials referenced an April report from an ...

A new ‘microdosing’ trend lets pharmacies offer compounded versions of GLP-1 drugs even after the Food and Drug ...

In a complaint filed in a state court in Santa Rosa County on Thursday, Florida Attorney General James Uthmeier claimed the ...

The Food and Drug Administration’s recent approval of a second generic version of the abortion pill mifepristone has left people on both sides of the reproductive rights fight scrambling to interpret ...

The official, Dr. George F. Tidmarsh, a top regulator at the agency, said disagreements over a new program to rapidly approve medications had caused tensions with agency officials.

The American Telemedicine Association and more than 450 stakeholder organizations issued a letter to Congressional leaders ...

Telehealth company Hims & Hers Health Inc. said late Monday it is in "active discussions" with Denmark's Novo Nordisk A/S to make Wegovy available on its platform.

The director of the U.S. Food and Drug Administration's Center for Drug Evaluation and Research, George Tidmarsh, resigned on ...

Hims & Hers said that the discussions with Novo Nordisk (DK:NOVO.B) are ongoing, that "no definitive agreement" has been reached, and that the two companies may not reach one. Nonetheless, Hims & Hers ...

Eli Lilly led a Stocktwits poll, with 32% support, ahead of Novo Nordisk, Hims & Hers Health and Viking Therapeutics at 16%.